Evidence map›Paper›PMID 28874705›Full record

ArticleScientific reports2017

Serum lysophospholipid levels are altered in dyslipidemic hamsters.

Susana Suárez-García, Antoni Caimari, Josep Maria Del Bas, Manuel Suárez, Lluís Arola

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Susana Suárez-GarcíaNutrigenomics Research Group, Department of Biochemistry and Biotechnology, Universitat Rovira i Virgili (URV), Tarragona, 43007, Spain.
Antoni CaimariTechnological Unit of Nutrition and Health. EURECAT-Technological Center of Catalonia, Reus, 43204, Spain.
Josep Maria Del BasTechnological Unit of Nutrition and Health. EURECAT-Technological Center of Catalonia, Reus, 43204, Spain.
Manuel SuárezNutrigenomics Research Group, Department of Biochemistry and Biotechnology, Universitat Rovira i Virgili (URV), Tarragona, 43007, Spain. manuel.suarez@urv.cat.
Lluís ArolaNutrigenomics Research Group, Department of Biochemistry and Biotechnology, Universitat Rovira i Virgili (URV), Tarragona, 43007, Spain.
Universidad Rovira i Virgili · ESTechnological Center of Nutrition and Health · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Dyslipidemias are common disorders that predispose individuals to severe diseases. It is known that healthy living habits can prevent dyslipidemias if they are diagnosed properly. Therefore, biomarkers that assist in diagnosis are essential. The aim of this study was to identify biomarkers of dyslipidemia progression, which in turn disclose its etiology. These findings will pave the way for examinations of the regulatory mechanisms involved in dyslipidemias. Hamsters were fed either a normal-fat diet (NFD) or a high-fat diet. Some of the NFD-fed animals were further treated with the hyperlipidemic agent Poloxamer 407. Non-targeted metabolomics was used to investigate progressive changes in unknown serum metabolites. The hepatic expression of putative biomarker-related genes was also analyzed. The serum levels of lysophospholipids (Lyso-PLs) and their related enzymes lecithin-cholesterol acyltransferase (LCAT), secreted phospholipase A

Indexed as

AnimalsBiomarkersChromatography, LiquidCricetinaeDisease ProgressionDyslipidemiasGene Expression ProfilingLipidsLysophospholipidsMaleMetabolomicsTandem Mass SpectrometryTranscriptomeBiomarkersLipidsLysophospholipids

Identifiers

PMID28874705
PMCPMC5585394
OpenAlexW2753578784

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.